Today: 10 June 2026
Rocket Lab stock drops nearly 10% as Neutron timing stays in focus ahead of Feb. 26 results

Rocket Lab stock drops nearly 10% as Neutron timing stays in focus ahead of Feb. 26 results

New York, Jan 26, 2026, 19:41 EST — After-hours

  • Rocket Lab shares fell 9.5% by the close, then inched up during after-hours trading
  • Company scheduled to report fourth-quarter and full-year 2025 results on Feb. 26, following the U.S. market close
  • Rocket Lab reported a schedule update for the February Neutron launch following a rupture during a Stage 1 tank test

Shares of Rocket Lab Corporation plunged 9.5% to close at $80.45 on Monday. In after-hours trading, the stock clawed back slightly, rising about 0.5% to $80.84.

Rocket Lab’s stock jumped around this week as investors pressed for clearer timelines on Neutron, the company’s upcoming rocket designed for heavier payloads. Two after-hours updates provided fresh dates — though not the definitive schedule many hoped for.

Rocket Lab announced Monday that it will release its fourth-quarter and full-year 2025 financial results after U.S. markets close on Feb. 26. The company also scheduled a conference call for 5 p.m. Eastern.

Separately, Rocket Lab announced that the “Hungry Hippo” captive fairing for Neutron has reached Wallops Island, Virginia. It will now undergo inspections before moving on to more pre-launch tests near Launch Complex 3. The payload fairing, which protects the spacecraft during ascent, is unique for Neutron—it stays attached throughout the mission and return. GlobeNewswire

Neutron’s progress has sparked volatility since Rocket Lab revealed in an SEC filing last week that a Stage 1 tank burst during a hydrostatic pressure test, which stresses the tank to verify its strength. The company is now analyzing the data to understand how this might affect Neutron’s launch timeline.

The company confirmed that production of the next Stage 1 tank is underway and intends to provide an update on Neutron’s timeline during its February earnings call.

Rocket Lab’s shares fluctuated from $80.01 up to $87.16 on Monday, as over 21 million shares exchanged hands, data from Stock Analysis shows.

Neutron aims to be a reusable, medium-lift rocket—a field currently led by SpaceX’s Falcon 9. Rocket Lab markets it as a bigger step beyond its smaller Electron launcher, targeting more substantial government and commercial missions.

The downside is clear: any delays in Neutron’s test flights could push back its first launch, prompting investors to slash near-term growth forecasts as the company keeps burning cash on development.

Rocket Lab will report earnings after the close on Feb. 26, followed by a conference call at 5 p.m. Eastern. The company has indicated it will use that call to provide its latest update on the Neutron schedule.

Stock Market Today

  • Joby Aviation Shares Fall 4.47% After CFO Stock Sale Amid Certification Wait
    June 10, 2026, 5:54 PM EDT. Joby Aviation's shares declined 4.47% to $8.86 following a sale of 78,489 shares by CFO Rodrigo Brumana under a pre-set 10b5-1 trading plan, a mechanism allowing scheduled insider sales. The stock's dip occurred despite no new operational or certification announcements. Joby continues to pursue FAA certification for its eVTOL aircraft, aiming for early operations in 2026 under a federal pilot program. The company reported a $109.95 million net loss in Q1, with $2.47 billion in cash and equivalents providing a financial buffer. Overall market declines and the ongoing certification process weigh on investor sentiment in this speculative growth stock.

Latest articles

Parabilis Medicines (PBLS) soars 58% after $670 million IPO beats range

Parabilis Medicines (PBLS) soars 58% after $670 million IPO beats range

10 June 2026
Parabilis Medicines soared 58% above its $20 IPO price to close at $31.60 in its Nasdaq debut after raising a record $670 million, reflecting strong investor demand for its Helicon drug platform ahead of a pivotal Phase 3 desmoid tumor trial planned for 2027; Regeneron’s $75 million private placement added credibility.
Joby Aviation Shares Slip After CFO Files to Sell Stock

Joby Aviation Shares Slip After CFO Files to Sell Stock

10 June 2026
Joby Aviation fell 4.47% to $8.86 after CFO Rodrigo Brumana disclosed selling 78,489 shares under a prearranged 10b5-1 plan, with no new certification or commercial-launch updates, leaving investors focused on regulatory progress and cash burn as the key catalysts for the stock.
YY Group Shares Spike as Humanoid Robot Plans Unveiled

YY Group Shares Spike as Humanoid Robot Plans Unveiled

10 June 2026
YY Group Holding shares surged to $0.165 on heavy volume after announcing a commercial humanoid-robotics initiative using Unitree G1 robots and facility-management data, reframing the company as a robotics-and-AI data play; the rally comes despite 2025 net loss, dilution risk from a relaunched at-the-market share-sale program, and no disclosed robot-related revenue or contracts.
Exxon Mobil stock dips after hours as Baytown freeze and carbon-capture launch set up earnings week
Previous Story

Exxon Mobil stock dips after hours as Baytown freeze and carbon-capture launch set up earnings week

Lloyds share price today: LLOY.L ticks higher as sanctions fine fades and results loom
Next Story

Lloyds share price today: LLOY.L ticks higher as sanctions fine fades and results loom

Go toTop